That can be generic manufacturers.

The other piece that goes with the process in a startup is now in a customer development process but in agile engineering process.

What are they? Pharmacokinetics and pharmacodynamics.

And so you're asking yourself,

FDA, actually.

That is something that the Medicines Patent Pool cannot do.

Do you recommend pursuing these treatments now, for most cancer patients?

Food.

Don't let nutrition labels or advertising fool you.

(Laughter)

So what do I mean by that?

Patent holders, inventors that develop new medicines patent those inventions, but make those patents available to the Medicines Patent Pool.

And, by the way, this happens most in hippocampus I told you about.

His son will soon be 14 years old.

We manufacture them in house, ourselves. That keeps the costs down.

That's an enormous amount of waste of time and money that ends up on the floor.

One of the really interesting developments about this class is this whole customer development process.

We're working on drugs that will tickle this pathway to give you a better memory.

So what this really means is that for process instead of just going to execution first, hiring product managers, doing waterfall development, or maybe even agile nowadays, we're actually going to start with a customer development process coupled with some kind of agile engineering process.

Toyota and the Toyota production system actually have it for a hardware of decade before anybody in software who ever thought about it.

Would you take her inside?

Based on this trial, in April of this year, the FDA approved Tumor Treating Fields for the treatment of patients with recurrent GBM.

We made sure that we produced some things ourselves.

We've developed a vitamin supplement.

Is the research enterprise really unaware of this reality?

We built them exactly like we built them in large companies.

Apart from the awards it's won, it's portable and it's certified.

Already, I'll give you an example.

Hell, I'll even throw in a bottle of the curative.

This is offshore.

It includes evaluating every aspect of medications that we use in clinical practice.

But, naturally, you can't do this kind of thing without a little bit of market research.

It's a new product him and I've been working up.

And a very relevant thing is if you were a drug company and you were buying the patent to some pharmaceutical that had four years left so that you could have exclusive rights to develop that drug. and at this point, all of a sudden, now anyone can develop the drug, so that patent is worthless.

Begin reanimation sequence.

But to take baby steps to get there, first of all we want to look at drug design and production, or drug discovery and manufacturing.

We've developed a vitamin supplement.

I'm here at the Autodesk Gallery with David Larsson.

The washes are fairly inexpensive and quick to use.

You know, you have new diseases that require new drugs.

And then we turn the page of the magazine, and we see this now this is the page the FDA requires pharmaceutical companies to put into their ads, or to follow their ads, and to me, this is one of the most cynical exercises in medicine.

Could we use, let's say, pharmacological drugs to activate or inactivate brain cells?

The company itself, Oxitec, we've been working for the last 10 years, very much on a sort of similar development pathway that you'd get with a pharmaceutical company.

We focused more on the really serious energy problems of the future, and we produced products for the company.

So you could be building products anything from microprocessors to medical equipment to hardware, software, etc. using an iterative and incremental engineering process.